1400W 2HCl

別名: N-(3-(Aminomethyl)benzyl)acetamidine 中文名稱：N-[3-(氨甲基)芐基]乙脒二鹽酸鹽

目錄號：S8337 Purity: 99.89%

1400W (N-(3-(Aminomethyl)benzyl)acetamidine) 是iNOS的抑制劑，與iNOS緩慢、緊密地結(jié)合，具有選擇性。

1400W 2HCl Chemical Structure

CAS: 214358-33-5

規(guī)格	價格	庫存
10mM (1mL in DMSO)	1040.13	現(xiàn)貨
10mg	794.67	現(xiàn)貨
50mg	3251.58	現(xiàn)貨
200mg	8166.25	現(xiàn)貨
1g	24489.05	現(xiàn)貨
更大包裝有超大折扣
400-668-6834 [email protected]

產(chǎn)品質(zhì)控

批次：純度： 99.89%

99.89

1400W 2HCl相關(guān)產(chǎn)品

相關(guān)靶點	nNOS eNOS iNOS	點擊展開
相關(guān)產(chǎn)品	L-NAME HCl 2',5'-Dihydroxyacetophenone TPEN L-NMMA acetate	點擊展開
相關(guān)化合物庫	激酶抑制劑庫 FDA藥物庫天然產(chǎn)物庫已知活性藥物庫-I 高選擇性抑制劑庫	點擊展開

細胞實驗數(shù)據(jù)示例

細胞系	實驗類型	給藥濃度	孵育時間	活性描述	文獻信息(PMID)
RAW264.7	Antiinflammatory assay	50 uM	24 hrs	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite production at 50 uM treated 30 mins before LPS challenge measured after 24 hrs by Griess method	20447741
RAW264.7	Antiinflammatory assay	0.5 to 2 uM	2 hrs	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced COX-2 expression at 0.5 to 2 uM incubated for 2 hrs prior to LPS challenge measured after 24 hrs by Western blot analysis	23232148
RAW264.7	Antiinflammatory assay	2 uM	2 hrs	Antiinflammatory activity in mouse RAW264.7 cells assessed as downregulation of LPS-induced iNOS mRNA expression at 2 uM incubated for 2 hrs prior to LPS challenge measured after 9 hrs by RT-PCR analysis	23232148
RAW264.7	Antiinflammatory assay	0.5 to 2 uM	2 hrs	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced iNOS expression at 0.5 to 2 uM incubated for 2 hrs prior to LPS challenge measured after 24 hrs by Western blot analysis	23232148
RAW264.7	Function assay	4 uM		Inhibition iNOS mRNA expression levels in LPS-induced mouse RAW264.7 cells at 4 uM by RT-PCR analysis	27542306
RAW264.7	Function assay	4 uM		Inhibition iNOS protein expression levels in LPS-induced mouse RAW264.7 cells at 4 uM by Western blot analysis	27542306
RAW264.7	Antiinflammatory assay		24 hrs	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay, IC50=0.2μM	23232148
RAW264.7	Antiinflammatory assay		20 hrs	Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as nitrite accumulation after 20 hrs by fluorimetry, IC50=0.3μM	11678654
RAW264.7	Antiinflammatory assay		24 hrs	Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs, IC50=2.9μM	15568764
RAW264.7	Antiinflammatory assay		24 hrs	Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as effect on NO production pretreated 1 hr before LPS challenge measured after 24 hrs, IC50=3.1μM	11908984
RAW 264	Function assay		24 hrs	Inhibition of 1ug/ml LPS-stimulated nitirc oxide accumulation in RAW 264 cells after 24 hrs, IC50=5.2μM	17320246
N9	Antiinflammatory assay		24 hrs	Antiinflammatory activity against mouse N9 cells assessed as inhibition of LPS/IFN-gamma-induced nitrite accumulation after 24 hrs, IC50=6.3μM	15568764
RAW264.7	Cytotoxicity assay		24 hrs	Cytotoxicity against mouse RAW264.7 cells assessed as cell viability after 24 hrs by MTS assay, IC50=47.47μM	23232148
RAW264.7	Function assay			Inhibition of LPS-induced nitric oxide generation in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by Griess method, IC50=1.5μM	19278854
N9	Function assay			Inhibitory effect of compound on the accumulation of NO2 in the culture media of N9 cells in response to LPS/IFN-gamma, IC50=2.2μM	15013012
RAW264.7	Antiinflammatory assay			Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production pretreated 1 hr before LPS challenge, IC50=2.3μM	12662101
RAW264.7	Function assay			Inhibition of LPS-induced nitric oxide accumulation in mouse RAW264.7 cells, IC50=2.7μM	19699097
N9	Antiinflammatory assay			Antiinflammatory activity in LPS/IFN-gamma-stimulated mouse N9 cells assessed as inhibition of nitric oxide production pretreated 1 hr before LPS/IFNgamma challenge, IC50=3.6μM	12662101
RAW264.7	Function assay			Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells, IC50=3.78μM	17988874
RAW264.7	Function assay			Inhibitory effect of compound on the accumulation of NO2 in the culture media of RAW 264.7 cells in response to LPS, IC50=6.1μM	15013012
點擊查看更多細胞系數(shù)據(jù)

生物活性

產(chǎn)品描述

1400W (N-(3-(Aminomethyl)benzyl)acetamidine) 是iNOS的抑制劑，與iNOS緩慢、緊密地結(jié)合，具有選擇性。

靶點

iNOS ^[1] (Cell-free assay)	nNOS ^[1] (Cell-free assay)	eNOS ^[1] (Cell-free assay)
<7 nM(Kd)	2 μM(Ki)	50 μM(Ki)

體外研究(In Vitro)
體外研究活性	1400W是一種不可逆的抑制劑或是一種具有積極緩慢的可逆性的抑制劑，抑制iNOS。1400對于人源iNOS的抑制作用是時間依賴性的。1400W與L-arginine屬于競爭關(guān)系，不是iNOS的底物^[1]。
細胞實驗	細胞系	RAW264.7細胞
	濃度	100 μM
	孵育時間	16 h
	方法	用LPS/IFNγ和iNOS的抑制劑1400W（100 μM）處理RAW264.7，處理16小時。GAPDH-P300的結(jié)合被1400W抑制。獲取細胞裂解液，用anti-p300的抗體進行免疫沉淀，免疫沉淀物用于WB分析。

體內(nèi)研究(In Vivo)
體內(nèi)研究活性	1400W在大鼠中選擇性地抑制微脈管系統(tǒng)損傷。在大鼠內(nèi)毒素誘導(dǎo)的血管損傷模型中，1400W對iNOS的抑制作用比eNOS有效50倍以上。除此之外，1400W還在結(jié)腸、肝臟、腎臟和心臟處濃度依賴性地減少LPS誘導(dǎo)的、與iNOS誘導(dǎo)相關(guān)的血管滲漏.對于除去腎臟的其他器官，其保護作用幾近100%，而在腎臟中式54%^[1]。1400W在腎臟缺血再灌注的大鼠模型中，對腎臟的氧化和硝化壓力具有改善作用^[2]。在小鼠中，處理以1400W可以減少實體瘤的生長速率^[4]。
動物實驗	Animal Models	大鼠
	Dosages	0.1-10 mg/kg
	Administration	皮下注射

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
臨床試驗信息 (data from https://clinicaltrials.gov, updated on 2024-05-22)
NCT00845169	Completed	Endothelial Dysfunction	University of Edinburgh\|NHS Lothian\|Ume? University	April 2012	Not Applicable

參考文獻
https://pubmed.ncbi.nlm.nih.gov/9030556/ https://pubmed.ncbi.nlm.nih.gov/19814638/ https://pubmed.ncbi.nlm.nih.gov/18552833/ https://pubmed.ncbi.nlm.nih.gov/9242464/ + 展開

參考文獻

https://pubmed.ncbi.nlm.nih.gov/9030556/
https://pubmed.ncbi.nlm.nih.gov/19814638/
https://pubmed.ncbi.nlm.nih.gov/18552833/

https://pubmed.ncbi.nlm.nih.gov/9242464/

+ 展開

化學(xué)信息&溶解度

分子量	250.17	分子式	C₁₀H₁₅N₃.2HCl
CAS號	214358-33-5	SDF	Download 1400W 2HCl SDF
Smiles	CC(=NCC1=CC=CC(=C1)CN)N.Cl.Cl
儲存條件(自收到貨起)	3年-20°C粉狀	儲備液保存和期限建議分裝儲備液，避免反復(fù)凍融！	1年-80°C溶于溶劑
儲存條件(自收到貨起)	3年-20°C粉狀	儲備液保存和期限建議分裝儲備液，避免反復(fù)凍融！	1個月-20°C溶于溶劑

體外溶解度
批次：

DMSO : 35 mg/mL ( (139.9 mM) ；DMSO吸濕會降低化合物溶解度，請使用新開封DMSO)

Water : 35 mg/mL (139.9 mM)

Ethanol : 35 mg/mL (139.9 mM)

DMSO : 50 mg/mL ( (199.86 mM) ；DMSO吸濕會降低化合物溶解度，請使用新開封DMSO)

Water : 50 mg/mL (199.86 mM)

Ethanol : 13 mg/mL (51.96 mM)

DMSO : 50 mg/mL ( (199.86 mM) ；DMSO吸濕會降低化合物溶解度，請使用新開封DMSO)

Water : 50 mg/mL (199.86 mM)

Ethanol : 12 mg/mL (47.96 mM)

摩爾濃度計算器

體內(nèi)溶解配方批次：現(xiàn)配現(xiàn)用，請按從左到右的順序依次添加，澄清后再加入下一溶劑				動物體內(nèi)配方計算器
均勻懸濁液	CMC-NA	≥5mg/ml	以 1 mL 工作液為例，取 5 mg該產(chǎn)品加到 1 ml CMC-NA 溶液中，混合均勻，即可得工作液濃度為 5 mg/ml的均勻懸濁液。
均勻懸濁液	CMC-NA	≥5mg/ml	以 1 mL 工作液為例，取 5 mg該產(chǎn)品加到 1 ml CMC-NA 溶液中，混合均勻，即可得工作液濃度為 5 mg/ml的均勻懸濁液。
均勻懸濁液	CMC-NA	≥5mg/ml	以 1 mL 工作液為例，取 5 mg該產(chǎn)品加到 1 ml CMC-NA 溶液中，混合均勻，即可得工作液濃度為 5 mg/ml的均勻懸濁液。

實驗計算

摩爾濃度計算器

質(zhì)量	濃度	體積	分子量
=	×	×

稀釋計算器分子量計算器

動物體內(nèi)配方計算器（澄清溶液）

第一步：請輸入基本實驗信息（考慮到實驗過程中的損耗，建議多配一只動物的藥量）

給藥劑量 mg/kg 動物平均體重 g 每只動物給藥體積 μL 動物數(shù)量只

第二步：請輸入動物體內(nèi)配方組成（配方適用于不溶于水的藥物；不同批次藥物配方比例不同，請聯(lián)系Selleck為您提供正確的澄清溶液配方）

% DMSO + % + % Tween 80 + % ddH2O

%DMSO+ %

計算結(jié)果：

工作液濃度： mg/ml；

DMSO母液配制方法： mg 藥物溶于μL DMSO溶液（母液濃度mg/mL，注：如該濃度超過該批次藥物DMSO溶解度，請先聯(lián)系Selleck）；

體內(nèi)配方配制方法：取μL DMSO母液，加入μL PEG300，混勻澄清后加入μL Tween 80，混勻澄清后加入μL ddH₂O，混勻澄清。

體內(nèi)配方配制方法：取μL DMSO母液，加入μL Corn oil，混勻澄清。

注意：1. 首先保證母液是澄清的；
2.一定要按照順序依次將溶劑加入，進行下一步操作之前必須保證上一步操作得到的是澄清的溶液，可采用渦旋、超聲或水浴加熱等物理方法助溶。

技術(shù)支持

在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段，您遇到的任何問題，均可以通過撥打我們的熱線電話400-668-6834，或者技術(shù)支持郵箱[email protected]，直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。

操作手冊

如果有其他問題，請給我們留言。

* 必填項

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):